RxDoctor Payments Data

Lisa Daly

Psychiatric/Mental Health · Elmira, NYNPI 1841631751

Payments from drug & device makers

$4,470in general payments, 2019–2025

Across 206 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$895
  • Johnson & Johnson$825
  • Neurocrine Biosciences, Inc.$619
  • Axsome Therapeutics, Inc.$576
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$478
  • Otsuka America Pharmaceutical, Inc.$339
  • plus $739 from 11 others

What the payments were for

  • Speaking & faculty fees$150%
  • Food & beverage$4,29796%
  • Education$1584%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,470 in reported general payments places this provider in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
AuvelityDextromethorphan Hbr/Bupropion25$40,840
Invega SustennaPaliperidone Palmitate16$37,304
VraylarCariprazine Hcl12$16,711
Aripiprazole25$5,334
Bupropion XlBupropion Hcl27$3,910
Vilazodone Hcl13$2,051
Quetiapine Fumarate50$1,694
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine16$1,289
Clozapine21$1,188
Ziprasidone Hcl12$1,084
Buspirone Hcl59$1,028
Venlafaxine Hcl ErVenlafaxine Hcl33$871
Alprazolam93$751
Duloxetine Hcl23$705
Sertraline Hcl44$573

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Axsome Therapeutics, Inc.Auvelity$576$40,84025 claims
Johnson & JohnsonInvega Sustenna$825$37,30416 claims
AbbVieVraylar$193$16,71112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Elmira

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →